| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |